Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Особенности течения периодической болезни в сочетании с серонегативным спондилоартритом - Журнал Терапевтический архив №5 Вопросы ревматологии 2024
Особенности течения периодической болезни в сочетании с серонегативным спондилоартритом
Гиносян К.В., Варданян В.С., Егиазарян Н.Г., Джндоян З.Т., Казинян И.С., Баблумян А.Ю. Особенности течения периодической болезни в сочетании с серонегативным спондилоартритом. Терапевтический архив. 2024;96(5):511–516. DOI: 10.26442/00403660.2024.05.202706
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Периодическая болезнь (ПБ), или семейная средиземноморская лихорадка, – аутосомно-рецессивное заболевание, распространенное в популяциях средиземноморского происхождения, в частности среди армян, евреев-сефардов, арабов, турков. Существует множество клинических наблюдений о сочетании ПБ как типичного представителя аутовоспалительных заболеваний и системных заболеваний соединительной ткани как классических аутоиммунных заболеваний. В этом плане большой интерес представляют серонегативные спондилоартриты (СНСА), так как сакроилеит, являющийся патогномоничным признаком данного заболевания, довольно часто проявляется в качестве составной части суставного синдрома при ПБ. Целью данного исследования явилось изучение особенностей течения ПБ и СНСА при их сочетании. Изучены 126 больных с ПБ и СНСА, а также их сочетанием. Согласно полученным результатам сочетание ПБ-СНСА имеет относительно мягкое течение по сравнению и с СНСА, и с ПБ в отдельности. Сравнительная клинико-инструментальная характеристика ПБ-ассоциированных заболеваний выявила, что при сочетании ПБ-СНСА наблюдается менее тяжелое течение как в отношении симптомов ПБ, так и симптомов СНСА.
Ключевые слова: периодическая болезнь, серонегативный спондилоартрит, сакроилеит
Keywords: familial Mediterranean fever, seronegative spondyloarthritis, sacroiliitis
Ключевые слова: периодическая болезнь, серонегативный спондилоартрит, сакроилеит
________________________________________________
Keywords: familial Mediterranean fever, seronegative spondyloarthritis, sacroiliitis
Полный текст
Список литературы
1. Nir-Paz R, Ben-Chetrit E, Pikarsky T, et al. Unusual presentation of familial Mediterranean fever: role of genetic diagnosis. Ann Rheum Dis. 2000;59:836-8. DOI:10.1136/ard.59.10.836
2. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449-54. DOI:10.1007/s00431-003-1223-x
3. Lachmann H, Sengul B, Yavuzsen T, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50. DOI:10.1093/rheumatology/kei279
4. Tunca M, Kirkali G, Soyturk M, et al. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353:1415. DOI:10.1016/S0140-6736(99)00990-3
5. Oktem S, Yavuszen B, Sengui B, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol. 2004;23:333-7. DOI:10.1007/s10067-004-0925-4
6. McDermott M, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-44. DOI:10.1016/s0092-8674(00)80721-7
7. Aksu K, Keser G. Coexistence of vasculitides with Familial Mediterranean fever. Rheumat Int. 2011;31(10):1263-74. DOI:10.1007/s00296-011-1840-z
8. Yildiz G, Kayatas M, Uygun Y, et al. Coexistence of systemic lupus erythematosus and familial Mediterranean fever. Intern Med. 2010;49:767-9. DOI:10.2169/internalmedicine.49.3102
9. Schwartz T, Langevitz P, Zemer D, et al. Behcet’s disease in Familial Mediterranean Fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000;29:286-95. DOI:10.1016/s0049-0172(00)80015-3
10. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet’s disease. Hum Mutat. 2000;16:271-2. DOI:10.1002/1098-1004(200009)16:3
11. Georgin-Lavialle S, Stojanovic K, Bachmeye C, et al. Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra. Rheumatology.
2017;56:167-9. DOI:10.1093/rheumatology/kew290
12. Ozgocmen S, Ozcakar L, Ardicoglu O, et al. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol. 2006;25:83-7.
DOI:10.1007/s10067-005-1122-9
13. Sarikaya S, Ozdolap S, Marasli E. Spondylitis and arthritis in Familial Mediterranean fever. Turk J Rheumatol. 2012;27(4):241-7. DOI:10.5606/tjr.2012.043
14. Cosan F, Ustek D, Oku B. Association of familial Mediterranean fever-related gene variations with ankylosing spondylitis. Arthritis Rheum. 2010;62(11):3232-6. DOI:0.1002/art.27683
15. Cinar M, Dinc A, Simsek I, et al. The rate and signifficanse of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37-42. DOI:10.1007/s00296-008-0637-1
16. Ozdolap S, Sarikaya S, Aktunc E. Familial Mediterranean fever assoiated with ankylozing spondylitis. Rheumatism. 2006;21:31-3. DOI:10.1007/s00296-005-0080-5
17. Kasifoglu T, Calisir C, Cansu D, et al. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009;28:41-6. DOI:10.1007/s10067-008-0980-3
18. Demirag M, Ozturk M, Goker M, et al. Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever. Rheumatol Int. 2008;29:77-9. DOI:10.1007/s00296-008-0631-7
19. Garrett S, Jenkinson T, Kennedy L, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.
20. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.
21. Doria Z, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmune Rev. 2012;12(1):22-30. DOI:10.1016/j.autrev.2012.07.018
22. Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67-72. DOI:10.1016/s0049-0172(97)80007-8
23. Balaban B, Yasar E, Ozgul A, et al. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int.
2005;25:641-4. DOI:10.1007/s00296-004-0578-2
24. Borman P, Gokoglu F, Tasbas O, et al. Familial Mediterranean fever-related spondyloarthropathy. Singapore Med J. 2009;50(3):116-9.
25. Incel N, Saracoglu M, Erdem H. Seronegative spondyloarthropathy of familial Mediterranean fever. Rheumatol Int. 2003;23:41-3. DOI:10.1007/s00296-002-0239-2
26. Altindag O, Karakoc M, Soran N, et al. Ankylosing spondylitis together with familial Mediterranean fever: A concomitant disease or a feature of FMF? Rheumatizm. 2007;22:110-3.
27. Sari I, Simsek I, Guvenc I, et al. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009;29:321-3.
DOI:10.1007/s00296-008-0660-2
28. Duman I, Balaban B, Tugcu I, et al. FMF unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int. 2007;27:689-90.
DOI:10.1007/s00296-006-0275-4
29. Keles I, Aydin G, Tosun A, et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int. 2006;26:846-51. DOI:10.1007/s00296-005-0080-5
30. Akkoc N, Sari I, Akar S, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: Additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 2010;62(10):3059-63. DOI:10.1002/art.27598
2. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449-54. DOI:10.1007/s00431-003-1223-x
3. Lachmann H, Sengul B, Yavuzsen T, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50. DOI:10.1093/rheumatology/kei279
4. Tunca M, Kirkali G, Soyturk M, et al. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353:1415. DOI:10.1016/S0140-6736(99)00990-3
5. Oktem S, Yavuszen B, Sengui B, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol. 2004;23:333-7. DOI:10.1007/s10067-004-0925-4
6. McDermott M, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-44. DOI:10.1016/s0092-8674(00)80721-7
7. Aksu K, Keser G. Coexistence of vasculitides with Familial Mediterranean fever. Rheumat Int. 2011;31(10):1263-74. DOI:10.1007/s00296-011-1840-z
8. Yildiz G, Kayatas M, Uygun Y, et al. Coexistence of systemic lupus erythematosus and familial Mediterranean fever. Intern Med. 2010;49:767-9. DOI:10.2169/internalmedicine.49.3102
9. Schwartz T, Langevitz P, Zemer D, et al. Behcet’s disease in Familial Mediterranean Fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000;29:286-95. DOI:10.1016/s0049-0172(00)80015-3
10. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet’s disease. Hum Mutat. 2000;16:271-2. DOI:10.1002/1098-1004(200009)16:3
11. Georgin-Lavialle S, Stojanovic K, Bachmeye C, et al. Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra. Rheumatology.
2017;56:167-9. DOI:10.1093/rheumatology/kew290
12. Ozgocmen S, Ozcakar L, Ardicoglu O, et al. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol. 2006;25:83-7.
DOI:10.1007/s10067-005-1122-9
13. Sarikaya S, Ozdolap S, Marasli E. Spondylitis and arthritis in Familial Mediterranean fever. Turk J Rheumatol. 2012;27(4):241-7. DOI:10.5606/tjr.2012.043
14. Cosan F, Ustek D, Oku B. Association of familial Mediterranean fever-related gene variations with ankylosing spondylitis. Arthritis Rheum. 2010;62(11):3232-6. DOI:0.1002/art.27683
15. Cinar M, Dinc A, Simsek I, et al. The rate and signifficanse of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37-42. DOI:10.1007/s00296-008-0637-1
16. Ozdolap S, Sarikaya S, Aktunc E. Familial Mediterranean fever assoiated with ankylozing spondylitis. Rheumatism. 2006;21:31-3. DOI:10.1007/s00296-005-0080-5
17. Kasifoglu T, Calisir C, Cansu D, et al. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009;28:41-6. DOI:10.1007/s10067-008-0980-3
18. Demirag M, Ozturk M, Goker M, et al. Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever. Rheumatol Int. 2008;29:77-9. DOI:10.1007/s00296-008-0631-7
19. Garrett S, Jenkinson T, Kennedy L, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.
20. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.
21. Doria Z, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmune Rev. 2012;12(1):22-30. DOI:10.1016/j.autrev.2012.07.018
22. Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67-72. DOI:10.1016/s0049-0172(97)80007-8
23. Balaban B, Yasar E, Ozgul A, et al. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int.
2005;25:641-4. DOI:10.1007/s00296-004-0578-2
24. Borman P, Gokoglu F, Tasbas O, et al. Familial Mediterranean fever-related spondyloarthropathy. Singapore Med J. 2009;50(3):116-9.
25. Incel N, Saracoglu M, Erdem H. Seronegative spondyloarthropathy of familial Mediterranean fever. Rheumatol Int. 2003;23:41-3. DOI:10.1007/s00296-002-0239-2
26. Altindag O, Karakoc M, Soran N, et al. Ankylosing spondylitis together with familial Mediterranean fever: A concomitant disease or a feature of FMF? Rheumatizm. 2007;22:110-3.
27. Sari I, Simsek I, Guvenc I, et al. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009;29:321-3.
DOI:10.1007/s00296-008-0660-2
28. Duman I, Balaban B, Tugcu I, et al. FMF unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int. 2007;27:689-90.
DOI:10.1007/s00296-006-0275-4
29. Keles I, Aydin G, Tosun A, et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int. 2006;26:846-51. DOI:10.1007/s00296-005-0080-5
30. Akkoc N, Sari I, Akar S, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: Additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 2010;62(10):3059-63. DOI:10.1002/art.27598
2. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449-54. DOI:10.1007/s00431-003-1223-x
3. Lachmann H, Sengul B, Yavuzsen T, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50. DOI:10.1093/rheumatology/kei279
4. Tunca M, Kirkali G, Soyturk M, et al. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353:1415. DOI:10.1016/S0140-6736(99)00990-3
5. Oktem S, Yavuszen B, Sengui B, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol. 2004;23:333-7. DOI:10.1007/s10067-004-0925-4
6. McDermott M, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-44. DOI:10.1016/s0092-8674(00)80721-7
7. Aksu K, Keser G. Coexistence of vasculitides with Familial Mediterranean fever. Rheumat Int. 2011;31(10):1263-74. DOI:10.1007/s00296-011-1840-z
8. Yildiz G, Kayatas M, Uygun Y, et al. Coexistence of systemic lupus erythematosus and familial Mediterranean fever. Intern Med. 2010;49:767-9. DOI:10.2169/internalmedicine.49.3102
9. Schwartz T, Langevitz P, Zemer D, et al. Behcet’s disease in Familial Mediterranean Fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000;29:286-95. DOI:10.1016/s0049-0172(00)80015-3
10. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet’s disease. Hum Mutat. 2000;16:271-2. DOI:10.1002/1098-1004(200009)16:3
11. Georgin-Lavialle S, Stojanovic K, Bachmeye C, et al. Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra. Rheumatology.
2017;56:167-9. DOI:10.1093/rheumatology/kew290
12. Ozgocmen S, Ozcakar L, Ardicoglu O, et al. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol. 2006;25:83-7.
DOI:10.1007/s10067-005-1122-9
13. Sarikaya S, Ozdolap S, Marasli E. Spondylitis and arthritis in Familial Mediterranean fever. Turk J Rheumatol. 2012;27(4):241-7. DOI:10.5606/tjr.2012.043
14. Cosan F, Ustek D, Oku B. Association of familial Mediterranean fever-related gene variations with ankylosing spondylitis. Arthritis Rheum. 2010;62(11):3232-6. DOI:0.1002/art.27683
15. Cinar M, Dinc A, Simsek I, et al. The rate and signifficanse of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37-42. DOI:10.1007/s00296-008-0637-1
16. Ozdolap S, Sarikaya S, Aktunc E. Familial Mediterranean fever assoiated with ankylozing spondylitis. Rheumatism. 2006;21:31-3. DOI:10.1007/s00296-005-0080-5
17. Kasifoglu T, Calisir C, Cansu D, et al. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009;28:41-6. DOI:10.1007/s10067-008-0980-3
18. Demirag M, Ozturk M, Goker M, et al. Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever. Rheumatol Int. 2008;29:77-9. DOI:10.1007/s00296-008-0631-7
19. Garrett S, Jenkinson T, Kennedy L, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.
20. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.
21. Doria Z, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmune Rev. 2012;12(1):22-30. DOI:10.1016/j.autrev.2012.07.018
22. Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67-72. DOI:10.1016/s0049-0172(97)80007-8
23. Balaban B, Yasar E, Ozgul A, et al. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int.
2005;25:641-4. DOI:10.1007/s00296-004-0578-2
24. Borman P, Gokoglu F, Tasbas O, et al. Familial Mediterranean fever-related spondyloarthropathy. Singapore Med J. 2009;50(3):116-9.
25. Incel N, Saracoglu M, Erdem H. Seronegative spondyloarthropathy of familial Mediterranean fever. Rheumatol Int. 2003;23:41-3. DOI:10.1007/s00296-002-0239-2
26. Altindag O, Karakoc M, Soran N, et al. Ankylosing spondylitis together with familial Mediterranean fever: A concomitant disease or a feature of FMF? Rheumatizm. 2007;22:110-3.
27. Sari I, Simsek I, Guvenc I, et al. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009;29:321-3.
DOI:10.1007/s00296-008-0660-2
28. Duman I, Balaban B, Tugcu I, et al. FMF unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int. 2007;27:689-90.
DOI:10.1007/s00296-006-0275-4
29. Keles I, Aydin G, Tosun A, et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int. 2006;26:846-51. DOI:10.1007/s00296-005-0080-5
30. Akkoc N, Sari I, Akar S, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: Additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 2010;62(10):3059-63. DOI:10.1002/art.27598
________________________________________________
2. Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449-54. DOI:10.1007/s00431-003-1223-x
3. Lachmann H, Sengul B, Yavuzsen T, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746-50. DOI:10.1093/rheumatology/kei279
4. Tunca M, Kirkali G, Soyturk M, et al. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999;353:1415. DOI:10.1016/S0140-6736(99)00990-3
5. Oktem S, Yavuszen B, Sengui B, et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol. 2004;23:333-7. DOI:10.1007/s10067-004-0925-4
6. McDermott M, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-44. DOI:10.1016/s0092-8674(00)80721-7
7. Aksu K, Keser G. Coexistence of vasculitides with Familial Mediterranean fever. Rheumat Int. 2011;31(10):1263-74. DOI:10.1007/s00296-011-1840-z
8. Yildiz G, Kayatas M, Uygun Y, et al. Coexistence of systemic lupus erythematosus and familial Mediterranean fever. Intern Med. 2010;49:767-9. DOI:10.2169/internalmedicine.49.3102
9. Schwartz T, Langevitz P, Zemer D, et al. Behcet’s disease in Familial Mediterranean Fever: Characterization of the association between the two diseases. Semin Arthritis Rheum. 2000;29:286-95. DOI:10.1016/s0049-0172(00)80015-3
10. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behcet’s disease. Hum Mutat. 2000;16:271-2. DOI:10.1002/1098-1004(200009)16:3
11. Georgin-Lavialle S, Stojanovic K, Bachmeye C, et al. Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra. Rheumatology.
2017;56:167-9. DOI:10.1093/rheumatology/kew290
12. Ozgocmen S, Ozcakar L, Ardicoglu O, et al. Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol. 2006;25:83-7.
DOI:10.1007/s10067-005-1122-9
13. Sarikaya S, Ozdolap S, Marasli E. Spondylitis and arthritis in Familial Mediterranean fever. Turk J Rheumatol. 2012;27(4):241-7. DOI:10.5606/tjr.2012.043
14. Cosan F, Ustek D, Oku B. Association of familial Mediterranean fever-related gene variations with ankylosing spondylitis. Arthritis Rheum. 2010;62(11):3232-6. DOI:0.1002/art.27683
15. Cinar M, Dinc A, Simsek I, et al. The rate and signifficanse of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int. 2008;29:37-42. DOI:10.1007/s00296-008-0637-1
16. Ozdolap S, Sarikaya S, Aktunc E. Familial Mediterranean fever assoiated with ankylozing spondylitis. Rheumatism. 2006;21:31-3. DOI:10.1007/s00296-005-0080-5
17. Kasifoglu T, Calisir C, Cansu D, et al. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 2009;28:41-6. DOI:10.1007/s10067-008-0980-3
18. Demirag M, Ozturk M, Goker M, et al. Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever. Rheumatol Int. 2008;29:77-9. DOI:10.1007/s00296-008-0631-7
19. Garrett S, Jenkinson T, Kennedy L, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-91.
20. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.
21. Doria Z, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmune Rev. 2012;12(1):22-30. DOI:10.1016/j.autrev.2012.07.018
22. Langevitz P, Livneh A, Zemer D, et al. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum. 1997;27:67-72. DOI:10.1016/s0049-0172(97)80007-8
23. Balaban B, Yasar E, Ozgul A, et al. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int.
2005;25:641-4. DOI:10.1007/s00296-004-0578-2
24. Borman P, Gokoglu F, Tasbas O, et al. Familial Mediterranean fever-related spondyloarthropathy. Singapore Med J. 2009;50(3):116-9.
25. Incel N, Saracoglu M, Erdem H. Seronegative spondyloarthropathy of familial Mediterranean fever. Rheumatol Int. 2003;23:41-3. DOI:10.1007/s00296-002-0239-2
26. Altindag O, Karakoc M, Soran N, et al. Ankylosing spondylitis together with familial Mediterranean fever: A concomitant disease or a feature of FMF? Rheumatizm. 2007;22:110-3.
27. Sari I, Simsek I, Guvenc I, et al. Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever. Rheumatol Int. 2009;29:321-3.
DOI:10.1007/s00296-008-0660-2
28. Duman I, Balaban B, Tugcu I, et al. FMF unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? Rheumatol Int. 2007;27:689-90.
DOI:10.1007/s00296-006-0275-4
29. Keles I, Aydin G, Tosun A, et al. Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int. 2006;26:846-51. DOI:10.1007/s00296-005-0080-5
30. Akkoc N, Sari I, Akar S, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: Additional evidence for a link with familial Mediterranean fever. Arthritis Rheum. 2010;62(10):3059-63. DOI:10.1002/art.27598
Авторы
К.В. Гиносян*1,2, В.С. Варданян1, Н.Г. Егиазарян1, З.Т. Джндоян1, И.С. Казинян1, А.Ю. Баблумян1,2
1Ереванский государственный медицинский университет им. Мхитара Гераци, Ереван, Армения;
2Университетская больница «Гераци», Ереван, Армения
*kginosyan@gmail.com
1Mkhitar Heratsi Yerevan State Medical University, Yerevan, Armenia;
2Geratsi University Clinic, Yerevan, Armenia
*kginosyan@gmail.com
1Ереванский государственный медицинский университет им. Мхитара Гераци, Ереван, Армения;
2Университетская больница «Гераци», Ереван, Армения
*kginosyan@gmail.com
________________________________________________
1Mkhitar Heratsi Yerevan State Medical University, Yerevan, Armenia;
2Geratsi University Clinic, Yerevan, Armenia
*kginosyan@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.